Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Central Retinal Vein Occlusion
NCT01468844Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Dec 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of minocycline in central retinal vein occlusion (CRVO), sponsored by National Eye Institute. Started Dec 2011; status: completed.
02
Drugs
minocycline
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on NCT01468844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01468844.